Left atrial volume index predicts future improvement of B-type natriuretic peptide levels after transcatheter aortic valve replacement
暂无分享,去创建一个
Y. Izumiya | M. Yoshiyama | Andrew T. Kim | S. Iwata | T. Shibata | Yosuke Takahashi | A. Ito | Ryosuke Yahiro | T. Okai | Tomohiro Yamaguchi | M. Ogawa | Yusuke Kure | Mana Ogawa | Asahiro Ito | Tsukasa Okai | Yasuhiro Izumiya | T. Yamaguchi
[1] M. Mack,et al. Five-Year Outcomes of Transcatheter or Surgical Aortic-Valve Replacement. , 2020, The New England journal of medicine.
[2] T. Nazif,et al. Low and elevated B-type natriuretic peptide levels are associated with increased mortality in patients with preserved ejection fraction undergoing transcatheter aortic valve replacement: an analysis of the PARTNER II trial and registry. , 2019, European heart journal.
[3] T. Akasaka,et al. Preoperative left atrial minimum volume as a surrogate marker of postoperative symptoms in senile patients with aortic stenosis who underwent surgical aortic valve replacement. , 2019, Journal of cardiology.
[4] Erwan Donal,et al. Left Atrial Structure and Function, and Left Ventricular Diastolic Dysfunction: JACC State-of-the-Art Review. , 2019, Journal of the American College of Cardiology.
[5] J. Leipsic,et al. Transcatheter Aortic‐Valve Replacement with a Balloon‐Expandable Valve in Low‐Risk Patients , 2019, The New England journal of medicine.
[6] Eric J Velazquez,et al. Guidelines for Performing a Comprehensive Transthoracic Echocardiographic Examination in Adults: Recommendations from the American Society of Echocardiography. , 2019, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[7] M. Desai,et al. B‐type natriuretic peptide is associated with remodeling and exercise capacity after transcatheter aortic valve replacement for aortic stenosis , 2018, Clinical cardiology.
[8] M. Niemelä,et al. Transcatheter and Surgical Aortic Valve Replacement in Patients with Recent Acute Heart Failure. , 2020, The Annals of thoracic surgery.
[9] Helmut Baumgartner,et al. [2017 ESC/EACTS Guidelines for the management of valvular heart disease]. , 2017, Kardiologia polska.
[10] A. Cribier,et al. Incidence, Prognostic Impact, and Predictive Factors of Readmission for Heart Failure After Transcatheter Aortic Valve Replacement. , 2017, JACC. Cardiovascular interventions.
[11] C. Tribouilloy,et al. Left Atrial Volume and Mortality in Patients With Aortic Stenosis , 2017, Journal of the American Heart Association.
[12] K. Takagi,et al. Elevation of B‐Type Natriuretic Peptide at Discharge is Associated With 2‐Year Mortality After Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis: Insights From a Multicenter Prospective OCEAN‐TAVI (Optimized Transcatheter Valvular Intervention–Transcatheter Aortic Valve , 2017, Journal of the American Heart Association.
[13] J. Muñiz,et al. Indexed left atrial size predicts all‐cause and cardiovascular mortality in patients undergoing aortic valve surgery , 2017, The Journal of thoracic and cardiovascular surgery.
[14] P. Wenaweser,et al. Effect of B-type natriuretic peptides on long-term outcomes after transcatheter aortic valve implantation. , 2015, The American journal of cardiology.
[15] M. Mack,et al. Prognostic value of serial B-type natriuretic peptide measurement in transcatheter aortic valve replacement (from the PARTNER Trial). , 2015, The American journal of cardiology.
[16] A. Jaffe,et al. B-type natriuretic peptide clinical activation in aortic stenosis: impact on long-term survival. , 2014, Journal of the American College of Cardiology.
[17] P. Pibarot,et al. Long-term prognostic value and serial changes of plasma N-terminal prohormone B-type natriuretic peptide in patients undergoing transcatheter aortic valve implantation. , 2014, The American journal of cardiology.
[18] M. Volpe,et al. Natriuretic peptides in cardiovascular diseases: current use and perspectives. , 2014, European heart journal.
[19] I. Barbash,et al. Correlation of brain natriuretic peptide levels in patients with severe aortic stenosis undergoing operative valve replacement or percutaneous transcatheter intervention with clinical, echocardiographic, and hemodynamic factors and prognosis. , 2013, American Journal of Cardiology.
[20] Y. Kanda,et al. Investigation of the freely available easy-to-use software ‘EZR' for medical statistics , 2012, Bone Marrow Transplantation.
[21] M. Takeuchi,et al. Measurement of left atrial volume from transthoracic three-dimensional echocardiographic datasets using the biplane Simpson's technique. , 2012, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[22] Jennifer Taylor,et al. ESC/EACTS Guidelines on the management of valvular heart disease. , 2012, European heart journal.
[23] R. Sacco,et al. Left atrial minimum volume and reservoir function as correlates of left ventricular diastolic function: impact of left ventricular systolic function , 2012, Heart.
[24] Stuart J Pocock,et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. , 2011, The New England journal of medicine.
[25] S. Pocock,et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. , 2010, The New England journal of medicine.
[26] C. Hassager,et al. Left atrial volume in patients with asymptomatic aortic valve stenosis (the Simvastatin and Ezetimibe in Aortic Stenosis study). , 2008, The American journal of cardiology.
[27] Richard B Devereux,et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardio , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[28] H. White,et al. Increased Plasma Natriuretic Peptide Levels Reflect Symptom Onset in Aortic Stenosis , 2003, Circulation.
[29] Pedro Lozano. Natriuretic peptides. , 2020, The Journal of the Arkansas Medical Society.
[30] R. Berger,et al. B-Type Natriuretic Peptide Predicts Sudden Death in Patients With Chronic Heart Failure , 2002, Circulation.
[31] B. Lorell,et al. Left ventricular hypertrophy: pathogenesis, detection, and prognosis. , 2000, Circulation.
[32] S A Glantz,et al. Left atrial relaxation and left ventricular systolic function determine left atrial reservoir function. , 1999, Circulation.